Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training in Long-Distance Runners (IRCT-LDR)
Immediate, Residual, and Cumulative Effects of Fartlek, Hill Circuit, and Roll-On Training Modalities: A Comprehensive Examination of Conditioning in Long-Distance Runners
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Long-distance running places substantial physiological and mechanical demands on athletes. Appropriate conditioning is therefore important for developing the capacity to tolerate training stress, recover effectively, and maintain or improve running performance. Different conditioning modalities may impose distinct physiological and mechanical demands, which may result in differences in immediate exercise responses, post-exercise recovery, training load, and longer-term adaptation.
This randomized controlled trial will compare three conditioning modalities. Fartlek training, hill circuit training, and roll-on training in well-trained long-distance runners. Twenty-one eligible runners will be randomly allocated to one of three parallel training groups: the Fartlek Training Group, Hill Circuit Training Group, or Roll-On Training Group. Each group will complete its assigned conditioning modality for 12 weeks, comprising 24 prescribed training sessions.
The study will examine three dimensions of response to conditioning. Immediate responses will include physiological and perceptual responses measured during or immediately after training. Residual responses will focus on recovery-related responses during the 24 hours following conditioning sessions. Cumulative responses will examine changes that develop over repeated exposure to the training intervention, including changes in running performance and aerobic fitness.
Repeated measurements will be collected throughout the intervention to characterize responses to the three conditioning modalities. Measures will include heart rate, blood lactate concentration, rating of perceived exertion, delayed-onset muscle soreness, recovery and wellness indicators, internal training load, 5-km time-trial performance, and VO₂max. Training-load measures will be derived from session rating of perceived exertion and session duration and will be used to characterize the training demands accumulated during the intervention.
The study will compare the response patterns among the three intervention groups to determine whether Fartlek, hill circuit, or roll-on training produces different immediate, residual, and cumulative responses in well-trained long-distance runners. The findings are intended to contribute evidence for the selection and progression of conditioning modalities while considering training stimulus, recovery, and performance-related responses.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Awoke Tibebu, MSc.
- Numéro de téléphone: +251912073305
- E-mail: awoket27@gmail.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
Male long-distance runners aged 18-25 years VO₂max greater than 60 mL/kg/min Weekly training volume of at least 60 km Training experience of at least 4 years Mercier score greater than 600 Currently engaged in regular long-distance running training Willing to participate in the 12-week training intervention Able to complete all required testing and monitoring procedures Provides written informed consent to participate in the study
Exclusion Criteria:
Current musculoskeletal injury that prevents participation in training or testing Known cardiovascular, respiratory, metabolic, or other medical condition that limits strenuous exercise Current illness or condition that prevents participation in the intervention Use of medication or other treatment that may substantially affect exercise performance or physiological responses Failure to meet the required training or eligibility criteria Planned absence that would prevent adequate participation in the intervention Withdrawal of informed consent Any condition identified by the research team that makes continued participation unsafe
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Fartlek Training Group (FTG)
A structured Fartlek running training intervention administered for 12 weeks to trained long-distance runners.
The intervention consists of planned variable-intensity running bouts with prescribed duration, repetitions, running intensity, recovery periods, and progressive workload according to the study protocol.
Training sessions will be supervised and standardized across participants.
|
A structured variable-intensity running intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, alternating faster and slower running at prescribed intensities, and prescribed recovery periods.
Running duration, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol.
Training sessions are supervised, and exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
|
Expérimental: Hill Circuit Training Group (HCTG)
Participants assigned to the Hill Circuit Training Group (HCTG) will receive the prescribed Hill Circuit training intervention during the 12-week randomized controlled trial.
The intervention consists of structured hill-running and circuit-based training designed for trained long-distance runners.
Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
|
A structured hill-running and circuit-based training intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, repeated uphill running bouts, running-based circuit exercises, and prescribed recovery intervals.
Hill gradient, running duration, repetitions, exercise intensity, recovery intervals, and workload progression are standardized according to the study protocol.
Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
|
Expérimental: Roll-On Training Group (ROTG)
Participants assigned to the Roll-On Training Group (ROTG) will receive the prescribed Roll-On training intervention during the 12-week randomized controlled trial.
The intervention consists of structured progressive running sessions designed for trained long-distance runners.
Training intensity, duration, repetitions, recovery periods, and progression will be prescribed according to the study protocol.
|
A structured progressive running intervention administered for 12 weeks to trained long-distance runners.
Each prescribed session includes standardized warm-up and cool-down periods, controlled running with planned gradual increases and decreases in running speed, and prescribed recovery periods where applicable.
Running duration, speed progression, intensity, repetitions, recovery intervals, and workload progression are standardized according to the study protocol.
Exercise intensity is monitored using heart rate, rating of perceived exertion, running pace, and prescribed workload.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
5-km Time-Trial Performance
Délai: Baseline week 6 and Week 12
|
Change in 5-km time-trial completion time from baseline to Week 6 and Week 12, comparing the Fartlek Training Group (FTG), Hill Circuit Training Group (HCTG), and Roll-On Training Group (ROTG).
|
Baseline week 6 and Week 12
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
VO₂max
Délai: Baseline, Week 6, and Week 12
|
Change in maximal oxygen uptake (VO₂max), measured in mL/kg/min, from baseline to Week 6 and Week 12, comparing FTG, HCTG, and ROTG.
|
Baseline, Week 6, and Week 12
|
|
Blood Lactate Concentration
Délai: Immediately pre-training and post-training during intervention sessions in Weeks 1-12
|
Change in blood lactate concentration, measured in mmol/L, immediately following prescribed conditioning sessions to characterize the acute physiological response to Fartlek, Hill Circuit, and Roll-On training.
|
Immediately pre-training and post-training during intervention sessions in Weeks 1-12
|
|
Rating of Perceived Exertion (RPE)
Délai: Immediately after each training session during Weeks 1-12
|
Session rating of perceived exertion will be measured using the OMNI perceived-exertion scale immediately following each conditioning session.
|
Immediately after each training session during Weeks 1-12
|
|
Heart Rate Response
Délai: During each training session during Weeks 1-12
|
Change in average and maximum heart rate during prescribed conditioning sessions to characterize the acute cardiovascular response to Fartlek, Hill Circuit, and Roll-On training.
|
During each training session during Weeks 1-12
|
|
Complete Blood Count (CBC)
Délai: Baseline, Week 6, and Week 12
|
Change in selected hematological parameters, including hemoglobin, hematocrit, red blood cell count parameters.
|
Baseline, Week 6, and Week 12
|
|
5-km Performance Score
Délai: Baseline and Week 12
|
Change in performance score calculated using the applicable World Athletics scoring table based on 5-km time-trial performance from baseline to Week 12, comparing FTG, HCTG, and ROTG.
|
Baseline and Week 12
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Delayed-Onset Muscle Soreness (DOMS)
Délai: Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
|
Change in self-reported muscle soreness following each prescribed conditioning session to assess post-exercise muscular recovery.
|
Immediately post-training and 24 hours after each conditioning session during Weeks 1-12
|
|
Recovery and Wellness
Délai: Before and 24 hours after each conditioning session during Weeks 1-12
|
Change in recovery and wellness indicators, including sleep duration, sleep quality, fatigue, stress, mood, and overall wellness score, assessed following conditioning sessions.
|
Before and 24 hours after each conditioning session during Weeks 1-12
|
|
Acute Training Load
Délai: Weeks 1-12
|
Weekly acute internal training load calculated from accumulated session training loads, where session training load is calculated as session duration multiplied by session rating of perceived exertion (sRPE).
|
Weeks 1-12
|
|
Chronic Training Load
Délai: Weeks 4-12
|
Chronic internal training load calculated as the rolling 4-week average of weekly training load during the intervention.
|
Weeks 4-12
|
|
Training Monotony
Délai: Weeks 1-12
|
Weekly training monotony calculated as the mean daily training load divided by the standard deviation of daily training load within each training week.
|
Weeks 1-12
|
|
Training Strain
Délai: Weeks 1-12
|
Weekly training strain calculated as weekly training load multiplied by training monotony during the 12-week intervention.
|
Weeks 1-12
|
|
Freshness Index
Délai: Weeks 1-12
|
Weekly freshness index calculated as chronic training load minus acute training load to characterize changes in training readiness during the intervention.
|
Weeks 1-12
|
|
Acute:Chronic Workload Ratio (ACWR)
Délai: Weeks 4-12
|
Weekly acute:chronic workload ratio calculated as acute training load divided by chronic training load during the intervention.
|
Weeks 4-12
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Directeur d'études: Alemayehu, PHd, University of Gonder
- Chaise d'étude: Gashaw, PHd, Bahir Dar University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- IRERC-19-2025
- bdu1500226 (Autre identifiant: Bahir Dar University)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
- ANALYTIC_CODE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .